-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Vera Therapeutics, Lowers Price Target to $34

Benzinga·08/11/2026 13:39:21
Listen to the news
Wedbush analyst Laura Chico maintains Vera Therapeutics (NASDAQ:VERA) with a Neutral and lowers the price target from $43 to $34.